Neurocrine Biosciences (NBIX) Amortizatization of Intangibles (2022 - 2026)
Neurocrine Biosciences (NBIX) recorded Amortizatization of Intangibles of $16.4 million in Q2 2026, compared with $1 million a year earlier.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends
On a TTM basis, Neurocrine Biosciences' Amortizatization of Intangibles came in at $18.6 million as of Jun 30, 2026, up 389.5% year-over-year; for FY2025, it was $4.1 million, up 13.9% from FY2024.
- Annual Amortizatization of Intangibles has increased for three straight years, with a three-year compound annual growth rate of 101.7% (FY2022 to FY2025).
- Across earlier years, Amortizatization of Intangibles came in at $3.6 million in FY2024 (+2.9%), $3.5 million in FY2023 (+600.0%) and $500,000 in FY2022.
- The Q2 2026 figure is the highest quarterly Amortizatization of Intangibles in data going back to Q4 2022.
- On a year-over-year basis, Amortizatization of Intangibles rose in five of the last seven quarters, with an average decline of 3.1%.
- Peak year-over-year performance for Amortizatization of Intangibles in the last five years was growth of 60.0% in Q4 2023, against a decline of 90.0% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $100,000 (Q1 2026), $1.1 million (Q4 2025) and $1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amort. of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 984.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 600.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Neurocrine Biosciences | 14.55 Bn | 10.25 Bn | 935.80 Mn | 16.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.40 Mn |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 900,000.00 |
| Sep 30, 2024 | 900,000.00 |
| Jun 30, 2024 | 900,000.00 |
| Mar 31, 2024 | 900,000.00 |
| Dec 31, 2023 | 800,000.00 |
| Sep 30, 2023 | 900,000.00 |
| Jun 30, 2023 | 900,000.00 |
| Mar 31, 2023 | 900,000.00 |
| Dec 31, 2022 | 500,000.00 |
API Access
Neurocrine Biosciences Amortizatization of Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=amortizatization-of-intangibles&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "amortizatization-of-intangibles", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=amortizatization-of-intangibles&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();